Europe OKs 1st one-dose drug to protect babies against RSV
Headline from The Buffalo News
The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year. In a statement Friday, drugmakers Sanofi
The Buffalo News's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year. In a statement Friday, drugmakers Sanofi
(CNN)- The U.S. may soon have a tool to fight some Respiratory Tract Infections caused by RSV. A preventative treatment for the ailment was approved by the European commission Friday, according to a spokesman for the drug-maker Sanofi.
By Jen Christensen, CNN A preventive treatment for lower respiratory tract infections caused by RSV got the go ahead from the European Commission on Friday, according to one of the companies that make it. The treatment is the first of its kind to protect all infants in their first year of life.
The injection, made by AstraZeneca and Sanofi, is the first to offer broad protection against respiratory syncytial virus among all newborns and infants.
The European Commission has authorized the world's first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year.
The European Commission has authorized the world’s first one-dose drug against a respiratory virus that sickens millions of babies and children globally every year.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
Europe OKs 1st one-dose drug to protect babies against RSV | Since Then
